Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy
Cureus · 07.06.2026
DOI: 10.7759/cureus.110414 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 07.06.2026. Verfasst von Latif Karahan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Hacettepe University Cancer Institute, Ankara, TUR. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology, Hacettepe University Cancer Institute, Ankara, TUR.
- Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, TUR.
Zitieren
APA
Karahan, L., Arslan, S., & Dizdar, O. (2026). Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy. Cureus. https://doi.org/10.7759/cureus.110414
Vancouver
Karahan L, Arslan S, Dizdar O. Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy. Cureus. 2026. doi:10.7759/cureus.110414
BibTeX
@article{Karahan2026,
author = {Karahan, Latif and Arslan, Sevtap and Dizdar, Omer},
title = {Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.110414}
}
EUVIMED